Transdermal Testosterone for Poor Responders Undergoing IVF
| Registry | NCT03078569 |
|---|---|
| Status | Unknown |
| Phase | Phase 4 |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 30 (Estimated) |
| Sponsor | Wolfson Medical Center (Other gov) |
| Conditions | Infertility, Female |
| Interventions | Testosterone gel (Drug) |
| Dates | start 2017-03-01 (estimated), primary completion 2018-03-01 (estimated), completion 2018-07-01 (estimated), first posted 2017-03-13, last updated 2017-03-13 |
| Locations | 1 site in Israel |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Infertility, Female All trials of Testosterone gel
This study evaluates the efficacy of pre- IVF treatment with transdermal testosterone to enhance ovarian response in poor responders.
a randomized controlled trial with two groups, treatment group with transdermal testosterone before IVF treatment and a control group with no treatment.
One of the major challenges of Assisted reproduction technology is treating women with low ovarian response,those women achieve very poor pregnancy rate with IVF.
in recent years there is a focus
| Arm | Type | Interventions | Description |
|---|---|---|---|
| testosterone gel | Experimental | Drug: Testosterone gel | testosterone gel treatment group |
| Control group | No intervention | without testosterone treatment |
Sex: Female, ages: 30 Years to 42 Years, accepts healthy volunteers
Inclusion Criteria: * infertility patients undergoing ART regular menses normal function of thyroid, liver and kidney normal BMI (19.3-28.9) without use of any fertility drugs in the previous two months Exclusion Criteria: * patients with recurrent implantations failure (3 cycles and more) previous ovarian surgery uncontrolled medical illness severe endometriosis (stage 3-4) contraindication for testosterone use
| Facility | City | Country | Status |
|---|---|---|---|
| Wolfson MC | Holon | Israel | Recruiting |